{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:35:19Z","timestamp":1793799319920,"version":"4.6.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Janssen Global Services, LLC, a Johnson & Johnson Company"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12325-025-03134-6","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:04:36Z","timestamp":1741853076000},"page":"2234-2247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Falls and Fractures in Patients with Geographic Atrophy: A US Claims Data Analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Allen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Teneralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyshah","family":"Abdul Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Garey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ackert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"12","key":"3134_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jamaophthalmol.2022.4401","volume":"140","author":"DB Rein","year":"2022","unstructured":"Rein DB, Wittenborn JS, Burke-Conte Z, et al. Prevalence of age-related macular degeneration in the US in 2019. JAMA Ophthalmol. 2022;140(12):1202\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.4401.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3134_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/s2214-109x(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106\u201316. https:\/\/doi.org\/10.1016\/s2214-109x(13)70145-1.","journal-title":"Lancet Glob Health"},{"issue":"5","key":"3134_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/IAE.0000000000001392","volume":"37","author":"DS Boyer","year":"2017","unstructured":"Boyer DS, Schmidt-Erfurth U, van Lookeren CM, Henry EC, Brittain C. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37(5):819\u201335. https:\/\/doi.org\/10.1097\/IAE.0000000000001392.","journal-title":"Retina"},{"issue":"4","key":"3134_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.mayocpiqo.2024.05.003","volume":"8","author":"N Boopathiraj","year":"2024","unstructured":"Boopathiraj N, Wagner IV, Dorairaj SK, Miller DD, Stewart MW. Recent updates on the diagnosis and management of age-related macular degeneration. Mayo Clin Proc Innov Qual Outcomes. 2024;8(4):364\u201374. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2024.05.003.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"3134_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2147\/OPTH.S445755","volume":"18","author":"CD Regillo","year":"2024","unstructured":"Regillo CD, Nijm LM, Shechtman DL, et al. Considerations for the identification and management of geographic atrophy: recommendations from an expert panel. Clin Ophthalmol. 2024;18:325\u201335. https:\/\/doi.org\/10.2147\/OPTH.S445755.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"3134_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","volume":"125","author":"U Chakravarthy","year":"2018","unstructured":"Chakravarthy U, Bailey CC, Johnston RL, et al. Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2018;125(6):842\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.036.","journal-title":"Ophthalmology"},{"issue":"6","key":"3134_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3341\/kjo.2021.0037","volume":"35","author":"JI You","year":"2021","unstructured":"You JI, Kim DG, Yu SY, Kim ES, Kim K. Correlation between topographic progression of geographic atrophy and visual acuity changes. Korean J Ophthalmol. 2021;35(6):448\u201354. https:\/\/doi.org\/10.3341\/kjo.2021.0037.","journal-title":"Korean J Ophthalmol"},{"key":"3134_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2024.07.025","author":"MV Cicinelli","year":"2024","unstructured":"Cicinelli MV, Barlocci E, Rissotto F, et al. The discrepancy between visual acuity decline and foveal involvement in geographic atrophy. Ophthalmol Retina. 2024. https:\/\/doi.org\/10.1016\/j.oret.2024.07.025.","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"3134_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","volume":"119","author":"AR Rudnicka","year":"2012","unstructured":"Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119(3):571\u201380. https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.027.","journal-title":"Ophthalmology"},{"issue":"1","key":"3134_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ajo.2015.04.003","volume":"160","author":"AR Rudnicka","year":"2015","unstructured":"Rudnicka AR, Kapetanakis VV, Jarrar Z, et al. Incidence of late-stage age-related macular degeneration in American Whites: systematic review and meta-analysis. Am J Ophthalmol. 2015;160(1):85\u201393.e3. https:\/\/doi.org\/10.1016\/j.ajo.2015.04.003.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"3134_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2023-001395","volume":"8","author":"PK Kaiser","year":"2023","unstructured":"Kaiser PK, Karpecki PM, Regillo CD, et al. Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment. BMJ Open Ophthalmol. 2023;8(1):e001395. https:\/\/doi.org\/10.1136\/bmjophth-2023-001395.","journal-title":"BMJ Open Ophthalmol"},{"key":"3134_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/OPTH.S226425","volume":"14","author":"PJ Patel","year":"2020","unstructured":"Patel PJ, Ziemssen F, Ng E, et al. Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use. Clin Ophthalmol. 2020;14:15\u201328. https:\/\/doi.org\/10.2147\/OPTH.S226425.","journal-title":"Clin Ophthalmol"},{"issue":"27","key":"3134_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.15585\/mmwr.mm6927a5","volume":"69","author":"B Moreland","year":"2020","unstructured":"Moreland B, Kakara R, Henry A. Trends in nonfatal falls and fall-related injuries among adults aged \u226565\u00a0years - United States, 2012\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69(27):875\u201381. https:\/\/doi.org\/10.15585\/mmwr.mm6927a5.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"3134_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/jgs.15304","volume":"66","author":"CS Florence","year":"2018","unstructured":"Florence CS, Bergen G, Atherly A, Burns E, Stevens J, Drake C. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc. 2018;66(4):693\u20138. https:\/\/doi.org\/10.1111\/jgs.15304.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"3134_CR15","doi-asserted-by":"publisher","first-page":"7589","DOI":"10.1167\/iovs.14-14262","volume":"55","author":"T Hong","year":"2014","unstructured":"Hong T, Mitchell P, Burlutsky G, Samarawickrama C, Wang JJ. Visual impairment and the incidence of falls and fractures among older people: longitudinal findings from the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci. 2014;55(11):7589\u201393. https:\/\/doi.org\/10.1167\/iovs.14-14262.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3134_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/s0161-6420(02)01935-8","volume":"110","author":"BE Klein","year":"2003","unstructured":"Klein BE, Moss SE, Klein R, Lee KE, Cruickshanks KJ. Associations of visual function with physical outcomes and limitations 5\u00a0years later in an older population: the Beaver Dam eye study. Ophthalmology. 2003;110(4):644\u201350. https:\/\/doi.org\/10.1016\/s0161-6420(02)01935-8.","journal-title":"Ophthalmology"},{"issue":"9021","key":"3134_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0140-6736(96)01440-7","volume":"348","author":"P Dargent-Molina","year":"1996","unstructured":"Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348(9021):145\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(96)01440-7.","journal-title":"Lancet"},{"issue":"2","key":"3134_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361. https:\/\/doi.org\/10.1002\/pst.433.","journal-title":"Pharm Stat"},{"key":"3134_CR19","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1016\/j.jval.2020.04.1400","volume":"23","author":"A Kim","year":"2020","unstructured":"Kim A, Shirnashen E, Campbell J, Devine B, Bansal A. PSS12 Characterizing the healthcare resource utilization and costs in patients with geographic atrophy secondary to age-related macular degeneration stratified by disease severity. Value Health. 2020;23:S364. https:\/\/doi.org\/10.1016\/j.jval.2020.04.1400.","journal-title":"Value Health"},{"issue":"6","key":"3134_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ajo.2006.06.058","volume":"142","author":"E Anastasopoulos","year":"2006","unstructured":"Anastasopoulos E, Yu F, Coleman AL. Age-related macular degeneration is associated with an increased risk of hip fractures in the Medicare database. Am J Ophthalmol. 2006;142(6):1081\u20133. https:\/\/doi.org\/10.1016\/j.ajo.2006.06.058.","journal-title":"Am J Ophthalmol"},{"key":"3134_CR21","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2147\/OPTH.S307603","volume":"15","author":"A Kim","year":"2021","unstructured":"Kim A, Devine B, Campbell J, Shirneshan E, Zhao C, Bansal A. Healthcare resource utilization and costs in patients with geographic atrophy secondary to age-related macular degeneration. Clin Ophthalmol. 2021;15:2643\u201351. https:\/\/doi.org\/10.2147\/OPTH.S307603.","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"3134_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/qjmed\/hcp064","volume":"102","author":"J Gribbin","year":"2009","unstructured":"Gribbin J, Hubbard R, Smith C, Gladman J, Lewis S. Incidence and mortality of falls amongst older people in primary care in the United Kingdom. QJM. 2009;102(7):477\u201383. https:\/\/doi.org\/10.1093\/qjmed\/hcp064.","journal-title":"QJM"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03134-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03134-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03134-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:51:06Z","timestamp":1744872666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03134-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3134"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03134-6","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Allen Hu received grants\/contracts from\u00a04D Molecular Therapeutics, AbbVie, Acelyrin, Alexion, Alimera Sciences, Annexin Pharmaceuticals, Annexon Biosciences, Apellis, Ashvattha Therapeutics, Aviceda Therapeutics, Bayer, Boehringer Ingelheim, Chengdu Kanghong, Clearside Biomedical, Cognition Therapeutics, Curacle, EyeBio, EyePoint Pharmaceuticals, Genentech, Graybug Vision, Henlius, Ionis, Iveric Bio, Janssen, Kodiak Sciences, LMRI, LumiThera, Lupin, Neurotech, Novartis, Ocular Therapeutix, Oculis, Ocuphire Pharma, Ophthotech, Opthea, Outlook Therapeutics, Oxurion, Regeneron, REGENXBIO, Rezolute, Roche, Sandoz, Smilebiotek Zhuhai Limited, Stealth BioTherapeutics, and UNITY; received\u00a0consulting fees from\u00a0Annexon Biosciences, Apellis, Bayer, Clearside Biomedical, Genentech, Janssen, Oculis, Outlook Therapeutics, Regeneron, Roche, and Stealth BioTherapeutics; participated in\u00a0speakers bureaus for\u00a0Apellis, Genentech, and Iveric Bio; and participated in advisory\/data safety monitoring boards for Clearside Biomedical.\u00a0Rachel E. Teneralli is an employee of Johnson & Johnson. Jessica Ackert is a former employee of Johnson & Johnson and is currently an employee at Sanofi. Rachelle Rodriguez is a former employee of Johnson & Johnson and is currently an employee at Star Epidemiology LLC. Alyshah Abdul Sultan is a former employee of Johnson & Johnson and is currently an employee at Sanofi. Colleen Garey is an employee of Panalgo, which received funding from Johnson & Johnson for this analysis. Rose Ong is an employee of Actelion Pharmaceuticals, Ltd., a Janssen Pharmaceutical Company of Johnson & Johnson.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was based on de-identified data collected from three US health care claims databases and did not include human participants; as such, this analysis was exempt from institutional review board oversight and informed consent was not required or obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}